Gender differences in the adverse events’ profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis

References

• BaggioGCorsiniAFloreaniAGianniniSZagonelVGender medicine: a task for the third millenniumClin Chem Lab Med201351471372723515103
   PubMed Web of Science ®Google Scholar
• KorenGNordengHMacLeodSGender differences in drug bioequivalence: time to rethink practicesClin Pharmacol Ther201393326026223299647
   PubMed Web of Science ®Google Scholar
• UenoKSatoHSex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugsHypertens Res201235324525022089536
   PubMed Web of Science ®Google Scholar
• SoldinOPMattisonDRSex differences in pharmacokinetics and pharmacodynamicsClin Pharmacokinet200948314315719385708
   PubMed Web of Science ®Google Scholar
• SpoletiniIVitaleCMalorniWRosanoGMSex differences in drug effects: interaction with sex hormones in adult lifeHandb Exp Pharmacol20122149110523027447
   PubMedGoogle Scholar
• MillerMAGender-based differences in the toxicity of pharmaceuticals – the Food and Drug Administration’s perspectiveInt J Toxicol200120314915211488556
   PubMed Web of Science ®Google Scholar
• LegatoMJPrinciples of Gender-Specific Medicine1st edSan DiegoElsevier, Academic Press20041396
   Google Scholar
• ChenMLLeeSCNgMJSchuirmannDJLeskoLJWilliamsRLPharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceuticsClin Pharmacol Ther20006851051711103754
   PubMed Web of Science ®Google Scholar
• GandhiMAweekaFGreenblattRMBlaschkeTFSex differences in pharmacokinetics and pharmacodynamicsAnn Rev Pharmacol Toxicol20044449952314744256
   PubMed Web of Science ®Google Scholar
• SchwartzJBThe influence of sex on pharmacokineticsClin Pharmacokinet20034210712112537512
   PubMed Web of Science ®Google Scholar
• AndersonGDSex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamicsJ Womens Health (Larchmt)200514192915692274
   PubMed Web of Science ®Google Scholar
• CasseseMZuberVClinical trials and gender medicineAnn Ist Super Sanita201147110010321430348
   PubMed Web of Science ®Google Scholar
• Agenda for research on women’s health for the 21st centuryA report of the Task Force on the NIH Women’s Health Research Agenda for the 21st CenturyNational Institute of Health Publication 99-4389Bethesda, MDU.S. Department of Health and Human Services, Public Health Service, National Institutes of Health1999
   Google Scholar
• AIFA Farmaci e Genere – Avviso alle Aziende Farmaceutiche 30/01/2013 [The Italian Medicines Agency (AIFA) Medicines and Gender – Communication to Pharmaceutical Companies 30th January 2013].
   Google Scholar
• ColomboDBelliaGVassellattiDZagniESgarbiSRizzoliSA gender-medicine post hoc analysis (MetaGeM) project to test sex differences in previous observational studies in different diseases: methodologyOpen Access J Clin Trials20146111116
   Google Scholar
• ColomboDCaputoAFinziAfor the PSYCHAE Study Group. Evolution of and risk factors for psychological distress in patients with psoriasis: the PSYCHAE studyInt J Immunopathol Pharmacol201023129730620378016
   PubMed Web of Science ®Google Scholar
• ColomboDChimentiSGrossiPon behalf of SYNERGY Study GroupPrevalence of past and reactivated viral infections and efficacy of cyclosporine A as monotherapy or in combination in patients with psoriatic arthritis. The SYNERGY Study: a longitudinal observational studyBiomed Res Int2014ID941767
   Web of Science ®Google Scholar
• AbbruzzeseGAntoniniABaronePLinguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson’s diseaseNeurol Sci20123361319132722307444
   PubMed Web of Science ®Google Scholar
• StocchiFAntoniniABaronePDEEP study group. Early DEtection of wEaring off in Parkinson disease: the DEEP studyParkinsonism Relat Disord201420220421124275586
   PubMed Web of Science ®Google Scholar
• SpallettaGCaltagironeCPadovaniAEVOLUTION study Working Group. Cognitive and affective changes in mild to moderate Alzheimer’s disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational studyPLoS One201492e8921624586603
   PubMed Web of Science ®Google Scholar
• BernabeiRRossiniPMDi CioccioLCompliance and caregiver satisfaction in Alzheimer’s Disease: results from the AXEPT StudyDement Geriatr Cogn Dis Extra20122141843223139687
   PubMedGoogle Scholar
• FinziAColomboDCaputoAfor the PSYCHAE Study Group. Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE StudyJ Eur Acad Dermatol Venereol2007211161116917894699
   PubMed Web of Science ®Google Scholar
• PonticelliCColomboDNovaraMBasiliscoGCETRA Study GroupGastrointestinal symptoms impair quality of life in Italian renal transplant recipients but are under-recognized by physiciansTranspl Int201023111126113420525020
   PubMed Web of Science ®Google Scholar
• IcenMCrowsonCSMcEvoyMTDannFJGabrielSEMaradit KremersHTrends in incidence of adult-onset psoriasis over three decades: a population-based studyJ Am Acad Dermatol20096039440119231638
   PubMed Web of Science ®Google Scholar
• EderLThavaneswaranAChandranVGladmanDDGender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritisAnn Rheum Dis201372457858222589379
   PubMed Web of Science ®Google Scholar
• BhutaniTWongJWBeboBFJrArmstrongAWAccess to health care in patients with psoriasis and psoriatic arthritis: data from National Psoriasis Foundation Survey PanelsJAMA Dermatol2013149671772123783152
   PubMed Web of Science ®Google Scholar
• HotardRSFeldmanSRFleischerABJrSex-specific differences in the treatment of severe psoriasisJ Am Acad Dermatol200042462062310727307
   PubMed Web of Science ®Google Scholar
• ZachariaeHZachariaeRBlomqvistKTreatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life StudyActa Derm Venereol200181211612111501648
   PubMed Web of Science ®Google Scholar
• LeeWReveilleJDDavis JrJCLearchTJWardMMWeismanMHAre there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohortAnn Rheum Dis20076663363817127685
   PubMed Web of Science ®Google Scholar
• QueiroRTejónPCotoPClinical differences between men and women with psoriatic arthritis: relevance of the analysis of genes and polymorphisms in the Major Histocompatibility Complex region and of the age at onset of psoriasisClin Dev Immunol2013201348269123690822
   PubMedGoogle Scholar
• ColomboDChimentiSGrossiPAPrevalence of acute and chronic viral seropositivity and characteristics of disease in patients with psoriatic arthritis treated with cyclosporine: a post hoc analysis from a sex point of view on the observational study of infectious events in psoriasis complicated by active psoriatic arthritisClin Cosmet Investig Dermatol2015917
   PubMedGoogle Scholar
• ColomboDBelliaGIl paziente psoriasico e l’attenzione alle differenze di genere: lo studio Gender Attention [The patient affected by psoriasis and the attention to gender differences: the GENDER-ATTENTION study]G Ital Dermatol Venereol2013Suppl 121 Italian
   Google Scholar
• LiRSinghMSex differences in cognitive impairment and Alzheimer’s diseaseFront Neuroendocrinol201435338540324434111
   PubMed Web of Science ®Google Scholar
• KieburtzKWunderleKBParkinson’s disease: evidence for environmental risk factorsMov Disord201328181323097348
   PubMed Web of Science ®Google Scholar
• KowalSLDallTMChakrabartiRStormMVJainAThe current and projected economic burden of Parkinson’s disease in the United StatesMov Disord20132831131823436720
   PubMed Web of Science ®Google Scholar
• HaaxmaCABloemBRBormGFGender differences in Parkinson’s diseaseJ Neurol Neurosurg Psych2007788819824
   PubMed Web of Science ®Google Scholar
• BabaYPutzkeJDWhaleyWRWszolekZKUittiRJGender and the Parkinson’s disease phenotypeJ Neurol2005252101201120516151602
   PubMed Web of Science ®Google Scholar
• HarizGMLindbergMHarizMBergenheimATGender differences in disability and health-related quality of life in patients with Parkinson’s disease treated with stereotactic surgeryActa Neurol Scand20031081283712807390
   PubMed Web of Science ®Google Scholar
• FernandezHHLapaneKLPredictors of mortality among nursing home residents with a diagnosis of Parkinson’s diseaseMed Sci Monit20028CR241CR24611951064
   PubMedGoogle Scholar
• GalvinJEPollackJMorrisJCClinical phenotype of Parkinson disease dementiaNeurology20066791605161117101891
   PubMed Web of Science ®Google Scholar
• ScaglioneCVignatelliVPlazziGREM sleep behaviour disorder in Parkinson’s disease: a questionnaire-based studyNeurol Sci200525631632115729494
   PubMed Web of Science ®Google Scholar
• LubomskyMRushworthRLLeeWBertramKLWilliamsDRSex differences in Parkinson’s diseaseJ Clin Neurosci20142191503150624767694
   PubMed Web of Science ®Google Scholar
• OloruntobaOOMoylanCAGender-based disparities in access to and outcomes of liver transplantationWorld J Hepatol20157346046725848470
   PubMedGoogle Scholar
• PirmohamedMJamesSMeakinSAdverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ2004329151915231615
   PubMed Web of Science ®Google Scholar
• PatelHBellDMolokhiaMTrends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005BMC Clin Pharmacol20077917894876
   PubMedGoogle Scholar
• SikdarKCAlaghehbandanRMacDonaldDAdverse drug events in adult patients leading to emergency department visitsAnn Pharmacother20104464164920233911
   PubMed Web of Science ®Google Scholar
• ColomboDGraziottinABelliaGVenaGABanfiGCassanoNInfluence of sex on incidence of side effects in plaque psoriasis patients treated with cyclosporine. Preliminary results from the Italian observational GENDER ATTENTION studyJ Am Acad Dermatol201470Suppl 1AB173
   Google Scholar
• FranconiFCampesiIPharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and womenBr J Pharmacol2014171358059423981051
   PubMed Web of Science ®Google Scholar
• FattingerKRoosMVergeresPEpidemiology of drug exposure and adverse drug reactions in two Swiss department of internal medicineBr J Clin Pharmacol20004915816710671911
   PubMed Web of Science ®Google Scholar